Session Details
[3LS05]The Past, Present, and Future of the PURE System
Thu. Dec 3, 2026 12:55 PM - 1:45 PM JST
Thu. Dec 3, 2026 3:55 AM - 4:45 AM UTC
Thu. Dec 3, 2026 3:55 AM - 4:45 AM UTC
Room 5 (Conference Center 3F 304)
Chairperson: Takashi Kanamori (GeneFrontier Corporation)
GeneFrontier Corporation
The Protein synthesis Using Recombinant Elements (PURE) system, a reconstituted cell-free protein synthesis platform, was developed in 2001 with the aim of constructing a protein synthesis system from the minimal set of necessary components. In contrast to conventional cell extract-based cell-free systems, the PURE system allows individual components to be freely manipulated, thereby enabling precise control and monitoring of the composition and progression of the reaction. This unique feature has made the system a powerful tool for detailed mechanistic studies and sophisticated engineering of the reaction.
Taking advantage of its highly defined and minimal composition, the PURE system has been utilized to analyze and reconstruct not only the translation machinery itself but also cellular processes coupled to translation. As a result, it has evolved into a significant platform for fundamental biochemical research, generating novel insights into biological systems.
Such diverse developments, many of which exceeded the original expectations for the technology, were facilitated by efforts to promote commercialization and broad dissemination through collaborations with companies, including GeneFrontier, rather than restricting access to the technology. In the future, the PURE system is expected to expand its applications toward the reconstruction of increasingly complex biological systems, including synthetic biology and artificial cell research.
In this seminar, I will discuss the past, present, and future of the PURE system.
Taking advantage of its highly defined and minimal composition, the PURE system has been utilized to analyze and reconstruct not only the translation machinery itself but also cellular processes coupled to translation. As a result, it has evolved into a significant platform for fundamental biochemical research, generating novel insights into biological systems.
Such diverse developments, many of which exceeded the original expectations for the technology, were facilitated by efforts to promote commercialization and broad dissemination through collaborations with companies, including GeneFrontier, rather than restricting access to the technology. In the future, the PURE system is expected to expand its applications toward the reconstruction of increasingly complex biological systems, including synthetic biology and artificial cell research.
In this seminar, I will discuss the past, present, and future of the PURE system.
[3LS05-01]The Past, Present, and Future of the PURE System
Yoshihiro Shimizu (Laboratory for Cell-Free Protein Synthesis, RIKEN Center for Biosystems Dynamics Research)
